Bispecific T cell activating antigen binding molecules
US11459404B2 · kind B2 · utility
2Cited by
24References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2017 |
| Grant date | Oct 4, 2022 |
| Priority date | — |
| Expiry date | Jun 6, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.